Concord Biotech Ltd Dividend 2024 : Should Concord Biotech Ltd be a part of your dividend portfolio?
Concord Biotech Ltd is one of the most popular Pharmaceuticals company in the world with a market capitalisation of ₹19,201.78Cr. Its share price is ₹1,835.90 as on 8 September,2024.
The dividend is a percentage of earnings paid out to shareholders. Last year, Concord Biotech Ltd gave ₹8.75 for the full year, but should it be a part of your investments that give good dividends?
Key Highlights
Pharmaceuticals stocks do not always pay a dividend but as Concord Biotech Ltd pays dividends to reward its shareholders.
In the quarter ending March 2024, Concord Biotech Ltd has declared dividend of ₹8.75 - translating a dividend yield of 0.48%.
Let's look at Concord Biotech Ltd’s capacity to pay dividends and consider its valuation to determine its virtues as a dividend stock:
Concord Biotech Ltd’s revenue were ₹227.46Cr in the quarter ending June 2024. The revenue grew by 9.61% year on year basis since last quarter.
Concord Biotech Ltd’s profits were ₹59.59Cr in the quarter ending June 2024. The profits grew by 9.36% year on year basis since last quarter.
Concord Biotech Ltd’s dividend was ₹8.75 in the quarter ending March 2024.
Concord Biotech Ltd Dividend related ratios:
Last dividend date: 23/05/2024
Current Dividend Yield: 0.48%
Annual dividend payment: ₹8.75
History of Concord Biotech Ltd's Dividend payments